TELA Bio (TELA) Revenue Growth (3y) (2021 - 2026)
TELA Bio (TELA) Revenue Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 8.07% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 9.66% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 14.78% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.83% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 14.51% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 3.20% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 25.44% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.05% |
| 10 | TELA Bio | 36.34 Mn | 5.92 Mn | 13.94 Mn | 10.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.00% |
| Mar 31, 2026 | 16.97% |
| Dec 31, 2025 | 21.55% |
| Sep 30, 2025 | 22.85% |
| Jun 30, 2025 | 24.74% |
| Mar 31, 2025 | 31.04% |
| Dec 31, 2024 | 28.21% |
| Sep 30, 2024 | 35.30% |
| Jun 30, 2024 | 28.64% |
| Mar 31, 2024 | 41.37% |
| Dec 31, 2023 | 44.22% |
| Sep 30, 2023 | 41.50% |
| Jun 30, 2023 | 60.48% |
| Mar 31, 2023 | 47.30% |
| Dec 31, 2022 | 33.69% |
| Sep 30, 2022 | 41.09% |
| Jun 30, 2022 | 46.60% |
| Mar 31, 2022 | 35.53% |
| Dec 31, 2021 | 51.11% |
| Sep 30, 2021 | 51.25% |